Stock Analysis

3 Stocks That May Be Trading Below Their Estimated Value In April 2025

NasdaqGS:PRVA
Source: Shutterstock

As the United States stock market navigates a period of volatility amid President Trump's anticipated announcement on new tariffs, major indices like the Dow Jones and S&P 500 have shown resilience with recent gains despite earlier declines. In such an unpredictable environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for growth while balancing the risks presented by ongoing economic uncertainties.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

NameCurrent PriceFair Value (Est)Discount (Est)
WesBanco (NasdaqGS:WSBC)$30.65$59.9348.9%
Semrush Holdings (NYSE:SEMR)$9.56$19.0349.8%
Berkshire Hills Bancorp (NYSE:BHLB)$26.09$51.4849.3%
Valley National Bancorp (NasdaqGS:VLY)$8.89$17.2848.6%
ACNB (NasdaqCM:ACNB)$41.36$82.2749.7%
AGNC Investment (NasdaqGS:AGNC)$9.49$18.5748.9%
Smurfit Westrock (NYSE:SW)$45.62$89.9549.3%
CI&T (NYSE:CINT)$5.99$11.7349%
Advanced Micro Devices (NasdaqGS:AMD)$102.78$204.2449.7%
Haemonetics (NYSE:HAE)$63.02$124.7149.5%

Click here to see the full list of 192 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

Lincoln Educational Services (NasdaqGS:LINC)

Overview: Lincoln Educational Services Corporation offers career-oriented postsecondary education services to high school graduates and working adults in the United States, with a market cap of approximately $501.38 million.

Operations: The company generates revenue through its Transitional segment, which accounts for $7.10 million, and Campus Operations, contributing $432.97 million.

Estimated Discount To Fair Value: 33.3%

Lincoln Educational Services is trading at US$16.16, significantly below its estimated fair value of US$24.23, suggesting it may be undervalued based on cash flows. Recent amendments to its credit agreement with Fifth Third Bank enhance financial flexibility, supporting growth initiatives. Despite a lower net profit margin compared to last year, earnings are expected to grow by 41% annually over the next three years, outpacing the broader US market's growth rate of 13.8%.

NasdaqGS:LINC Discounted Cash Flow as at Apr 2025
NasdaqGS:LINC Discounted Cash Flow as at Apr 2025

MetroCity Bankshares (NasdaqGS:MCBS)

Overview: MetroCity Bankshares, Inc. is a bank holding company for Metro City Bank, offering various banking products and services in the United States, with a market cap of approximately $700.35 million.

Operations: MetroCity Bankshares generates its revenue primarily through its Community Banking segment, which accounts for $140.69 million.

Estimated Discount To Fair Value: 48.2%

MetroCity Bankshares is trading at US$27.62, significantly below its estimated fair value of US$53.34, indicating potential undervaluation based on cash flows. With earnings forecasted to grow by 21.39% annually and revenue expected to increase by 21.7% per year, the company demonstrates robust growth prospects compared to the broader US market. Recent financial results show net interest income rising to US$30.06 million and net income increasing to US$16.24 million year-over-year, underscoring strong performance momentum.

NasdaqGS:MCBS Discounted Cash Flow as at Apr 2025
NasdaqGS:MCBS Discounted Cash Flow as at Apr 2025

Privia Health Group (NasdaqGS:PRVA)

Overview: Privia Health Group, Inc. is a national physician-enablement company operating in the United States with a market cap of approximately $2.71 billion.

Operations: The company generates revenue of $1.74 billion from its Healthcare Facilities & Services segment.

Estimated Discount To Fair Value: 42.9%

Privia Health Group's current trading price of US$22.88 is substantially below its estimated fair value of US$40.04, highlighting potential undervaluation based on cash flows. The company forecasts significant earnings growth at 30.4% annually, surpassing the broader market's expectations. Recent financial results show Q4 sales increased to US$460.9 million with net income rising to US$4.4 million year-over-year, although profit margins have slightly decreased from the previous year.

NasdaqGS:PRVA Discounted Cash Flow as at Apr 2025
NasdaqGS:PRVA Discounted Cash Flow as at Apr 2025

Turning Ideas Into Actions

Ready To Venture Into Other Investment Styles?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

If you're looking to trade Privia Health Group, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com